For Clinicians
Artfun+ biomarker has multiple clinical applications on several unmet markets in primary and secondary prevention
The Core Of Our Biomarker Is The Measurement Of Ascending Aortic Distensibility By MRI
ArtFun+ is an MRI analysis software enabling leading cardiovascular clinicians to optimize their cardiac MRIs with a new imaging biomarker for cardiovascular risk stratification: the Ascending Aortic Distensibility (AAD). AAD measures the stiffness of the central arteries by precisely tracking how the aorta moves and combining this information with the pressure in theblood vessels.
AAD with ArtFun+ have been shown to be the The strongest predictor of CV events and death at 8.5 years for intermediate/low risk patients using traditional risk factors. AAD has also been shown to be a powerful marker of early subclinical cardiovascular (CV) disease and one of the earliest indicators of aging.
ArtFun+ allows qualified clinicians to complement their cardiac MRI exams with the analysis of axial cine SSFP of the aorta, enabling a deep understanding of patients’ cardiovascular health status.
new imaging biomarker
for cardiovascular risk stratification
Biomarker of cardiovascular Risk: Early infraclinical disease, primary & secondary prevention.
Earliest marker of cardiovascular aging: Integrator of individual CV age and health over the lifespan.
Prime Determinant Of CV Efficiency: CV coupling and aortic function is a prime determinant of CV efficiency, making ArtFun+ measurements highly relevant to CV phenotyping.
Measured By MRI: Unique non-invasive assessment of the central arterial system
Quantifies rejuvenation: Reversibility
ArtFun+’ technology has shown that you could improve 4+ years of cardiovascular age by following a 6-months moderate sports program and other non-therapeutic prevention programs, as used at the London Bart’s Heart Center and highlighted on BBC News.
ArtFun+’s Biomarkers for Cardiovascular Check-Ups
Discover Cardioinspect a decision tool based on arfun+ biomarkers that helps cardiologist and clinics to start and monitor cardiovascular prevention by providing a personal report that screen the cardiovascular age and detect the earliest signs of cardiovacular disease.
ArtFun+’s Biomarkers For Secondary Prevention
ArtFun+ is currently addressing aortic aneurysm & coronary artery diseases
we aim to build a diversified portfolio of assets in different clinical applications
Systemic Impact Of High Central Vascular Stiffness
Heart
Myocardial Dysfunction & Heart Failure & Left Arterial Dysfunction & Reduced Coronary Flow Reserve
Brain
Subclinical Brain
& Pathology Cognitive
& Impairment / Dementia
Liver
Insulin Resistance
&
NASH
Kidney
Chronic Kidney Disease
Testicles
Testosterone Deficiency
Placenta-Fetal Unit
Pre-Eclampsia Intrauterine Growth Restriction
Let’s Drive Adoption
With More Clinical Applications